PMID

Data

Article Title

Organization

Ergoline derivatives as highly potent and selective antagonists at the somatostatin sst 1 receptor.

Novartis Institutes For Biomedical Research

SAR of the arylpiperazine moiety of obeline somatostatin sst1 receptor antagonists.

Novartis Institutes For Biomedical Research

Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists.

Novartis Institutes For Biomedical Research

Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed"click" cycloaddition and thio acid/sulfonyl azide"sulfo-click" amidation and their in vivo evaluation.

Utrecht University

Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism.

Crinetics Pharmaceuticals

Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.

Diatide Research Laboaratories

Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.

University of Arizona

Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.

Government College University